RTTNews | Feb 17, 2021 07:22AM EST

07:22 Wednesday, February 17, 2021 (RTTNews) - RedHill Biopharma Says First Patient Dosed In U.S. Phase 2/3 COVID-19 Outpatient Study With RHB-107

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved